A. David Burden

9.5k total citations · 1 hit paper
96 papers, 4.8k citations indexed

About

A. David Burden is a scholar working on Immunology, Dermatology and Pathology and Forensic Medicine. According to data from OpenAlex, A. David Burden has authored 96 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Immunology, 49 papers in Dermatology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in A. David Burden's work include Psoriasis: Treatment and Pathogenesis (58 papers), Dermatology and Skin Diseases (36 papers) and Autoimmune Bullous Skin Diseases (14 papers). A. David Burden is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (58 papers), Dermatology and Skin Diseases (36 papers) and Autoimmune Bullous Skin Diseases (14 papers). A. David Burden collaborates with scholars based in United Kingdom, Germany and United States. A. David Burden's co-authors include Catherine Smith, Juliet N. Barker, C.E.M. Griffiths, Nick J. Reynolds, Richard B. Warren, Anthony D. Ormerod, Kathleen McElhone, Francesca Capon, Zenas Z N Yiu and Alexander A. Navarini and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

A. David Burden

95 papers receiving 4.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trial of Spesolimab for Generalized Pustular Psoriasis

2021 194 citations H. Bachelez, Siew Eng Choon et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
A. David Burden	3.6k	2.5k	784	697	686	96	4.8k
E. Daudén	3.5k 1.0×	1.8k 0.7×	534 0.7×	699 1.0×	1.2k 1.7×	267	5.4k
Lotus Mallbris	3.5k 1.0×	2.1k 0.9×	739 0.9×	631 0.9×	1.2k 1.8×	96	4.8k
C. Papavassilis	3.8k 1.0×	2.3k 0.9×	711 0.9×	763 1.1×	913 1.3×	51	4.7k
Yves Poulin	3.9k 1.1×	4.7k 1.9×	801 1.0×	822 1.2×	1.0k 1.5×	169	7.1k
Andrea L. Neimann	3.8k 1.1×	1.7k 0.7×	541 0.7×	691 1.0×	1.3k 1.9×	33	5.2k
Reva Bhushan	2.7k 0.8×	2.3k 0.9×	274 0.3×	447 0.6×	676 1.0×	17	4.5k
Sandra Philipp	2.6k 0.7×	1.6k 0.6×	482 0.6×	338 0.5×	462 0.7×	79	3.5k
Richard B. Warren	6.2k 1.7×	3.4k 1.4×	1.1k 1.4×	1.0k 1.5×	1.9k 2.7×	344	8.1k
Melinda Gooderham	4.9k 1.4×	5.0k 2.0×	1.5k 1.9×	1.0k 1.5×	1.7k 2.5×	350	8.6k
J.M. Carrascosa	2.1k 0.6×	1.5k 0.6×	354 0.5×	383 0.5×	455 0.7×	211	3.0k

Countries citing papers authored by A. David Burden

Since Specialization

Citations

This map shows the geographic impact of A. David Burden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. David Burden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. David Burden more than expected).

Fields of papers citing papers by A. David Burden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. David Burden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. David Burden. The network helps show where A. David Burden may publish in the future.

Co-authorship network of co-authors of A. David Burden

This figure shows the co-authorship network connecting the top 25 collaborators of A. David Burden. A scholar is included among the top collaborators of A. David Burden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. David Burden. A. David Burden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Visvanathan, Sudha, H. Bachelez, Akimichi Morita, et al.. (2024). Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1. Journal of Investigative Dermatology. 145(3). 573–582.e8. 2 indexed citations

Burden, A. David, Yukari Okubo, Min Zheng, et al.. (2023). Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre‐specified patient subgroups in the Effisayil 1 study. Experimental Dermatology. 32(8). 1279–1283. 19 indexed citations

Burden, A. David, Robert Bissonnette, Alexander A. Navarini, et al.. (2023). Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study. Dermatology and Therapy. 13(10). 2279–2297. 13 indexed citations

Burden, A. David, H. Bachelez, Siew Eng Choon, et al.. (2023). The Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) score: online assessment and validation study of a specific measure of GPP disease activity. British Journal of Dermatology. 189(1). 138–140. 8 indexed citations

Smith, Catherine, Zenas Z N Yiu, Tracy Bale, et al.. (2023). British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023: a pragmatic update. British Journal of Dermatology. 190(2). 270–272. 8 indexed citations

Burden, A. David, Robert Bissonnette, Mark Lebwohl, et al.. (2023). Psychometric validation of the generalized pustular psoriasis physician global assessment (GPPGA) and generalized pustular psoriasis area and severity index (GPPASI). Journal of the European Academy of Dermatology and Venereology. 37(7). 1327–1335. 14 indexed citations

Cro, Suzie, Victoria Cornelius, Francesca Capon, et al.. (2022). The interleukin 1 receptor antagonist anakinra to reduce disease severity of palmoplantar pustulosis in adults: APRICOT RCT and PLUM mechanistic study. SHILAP Revista de lepidopterología. 9(2). 1–106. 1 indexed citations

Mason, K.J., A. David Burden, Juliet N. Barker, et al.. (2021). Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR. Journal of the European Academy of Dermatology and Venereology. 35(8). e498–e501. 4 indexed citations

Mason, K.J., A. David Burden, Juliet N. Barker, et al.. (2021). Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non‐biologic systemic therapies. Journal of the European Academy of Dermatology and Venereology. 35(8). e496–e498. 3 indexed citations

10.

Mahil, Satveer K., Martinsixtus Ezejimofor, L.S. Exton, et al.. (2020). Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta‐analysis. British Journal of Dermatology. 183(4). 638–649. 60 indexed citations

11.

Smith, Catherine, Satveer K. Mahil, Zenas Z N Yiu, et al.. (2020). Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis–Correction. Journal of Investigative Dermatology. 141(1). 177–181. 6 indexed citations

12.

Smith, Catherine, Zenas Z N Yiu, Tracy Bale, et al.. (2020). British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update. British Journal of Dermatology. 183(4). 628–637. 130 indexed citations

13.

Yiu, Zenas Z N, K.J. Mason, Juliet N. Barker, et al.. (2019). A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis. British Journal of Dermatology. 181(6). 1265–1271. 16 indexed citations

14.

Romano, Marco, Satveer K. Mahil, Siew Eng Choon, et al.. (2019). IL-36 Promotes Systemic IFN-I Responses in Severe Forms of Psoriasis. Journal of Investigative Dermatology. 140(4). 816–826.e3. 65 indexed citations

15.

Mahil, Satveer K., Nina Wilson, Nick Dand, et al.. (2019). Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR ). British Journal of Dermatology. 182(5). 1158–1166. 88 indexed citations

16.

Jabbar‐Lopez, Zarif K., Zenas Z N Yiu, L.S. Exton, et al.. (2017). Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis. Journal of Investigative Dermatology. 137(8). 1646–1654. 103 indexed citations

17.

Jabbar‐Lopez, Zarif K., Zenas Z N Yiu, L.S. Exton, et al.. (2017). Re: Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis. Journal of Investigative Dermatology. 137(12). 2644–2646. 6 indexed citations

18.

Yiu, Zenas Z N, L.S. Exton, Zarif K. Jabbar‐Lopez, et al.. (2016). Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-Analysis. Journal of Investigative Dermatology. 136(8). 1584–1591. 56 indexed citations

19.

Reich, Kristian, A. David Burden, James Eaton, & Neil Hawkins. (2011). Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials. British Journal of Dermatology. 166(1). 179–188. 157 indexed citations

20.

Allen, M H, Kati Asumalahti, Mahreen Ameen, et al.. (2002). Genetic analysis of PSORS1 single nucleotide polymorphisms in guttate psoriasis and palmoplantar pustulosis.. British Journal of Dermatology. 147(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact